For example, in a population-based registry cohort of non-squamous NSCLC patients presenting in northern New Zealand, we had previously shown that EGFR gene mutations were detected in 109 of 500 tested patients (22%) [1]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.